What is Amgen Inc.'s approach to research and development?

Amgen Inc.'s approach to research and development (R&D) is driven by their commitment to advancing innovative medicines for patients worldwide. They leverage an extensive expertise in biotechnology to discover, develop, and deliver transformative therapies. Amgen believes in harnessing the power of human biology to identify and address complex diseases. Their R&D efforts focus on six therapeutic areas, including oncology, cardiovascular disease, neuroscience, inflammation, bone health, and nephrology. They adopt a multidisciplinary approach by combining cutting-edge technologies with scientific expertise to accelerate the discovery and development of novel drugs. Amgen also prioritizes collaborations with external partners to foster a dynamic and diverse scientific community and enhance their R&D capabilities. Overall, Amgen's approach to R&D thrives on their relentless pursuit of scientific excellence and dedication to improving patients' lives.